TickerFactsScreenerDevelopers

Avalo Therapeutics, Inc. (AVTX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2013: -$12.93M2014: -$17.12M2015: -$11.01M2016: -$16.08M2017: $13.89M2018: -$35.38M2019: -$16.14M2020: -$72.84M2021: -$82.13M2022: -$37.44M2023: -$27.35M2024: -$68.51M2025: -$72.92M-$72.92M
2013Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$72.92M-6.4%
2024-$68.51M-150.5%
2023-$27.35M+26.9%
2022-$37.44M+54.4%
2021-$82.13M-12.8%
2020-$72.84M-351.4%
2019-$16.14M+54.4%
2018-$35.38M-354.7%
2017$13.89M+186.4%
2016-$16.08M-46.1%
2015-$11.01M+35.7%
2014-$17.12M-32.3%
2013-$12.93M—